Organotin(IV) derivatives of L-cysteine and their in vitro anti-tumor properties
dc.contributor.author | Chasapis, C. T. | en |
dc.contributor.author | Hadjikakou, S. K. | en |
dc.contributor.author | Garoufis, A. | en |
dc.contributor.author | Hadjiliadis, N. | en |
dc.contributor.author | Bakas, T. | en |
dc.contributor.author | Kubicki, M. | en |
dc.contributor.author | Ming, Y. | en |
dc.date.accessioned | 2015-11-24T16:43:38Z | |
dc.date.available | 2015-11-24T16:43:38Z | |
dc.identifier.issn | 1565-3633 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/8722 | |
dc.rights | Default Licence | - |
dc.subject | bioinorganic chemistry | en |
dc.subject | organotin(iv) compounds | en |
dc.subject | mercapto amino acids | en |
dc.subject | l-cysteine | en |
dc.subject | anti-tumour compounds | en |
dc.subject | acetyl-l-cysteine | en |
dc.subject | amino-acids | en |
dc.subject | crystal-structure | en |
dc.subject | ethyl-ester | en |
dc.subject | complexes | en |
dc.subject | tin | en |
dc.subject | penicillamine | en |
dc.subject | methionine | en |
dc.subject | ligands | en |
dc.title | Organotin(IV) derivatives of L-cysteine and their in vitro anti-tumor properties | en |
heal.abstract | The synthesis and characterization of the organotin compounds [(n-C4H9)(2)Sn(cys)] (1), [(C6H5)(2)Sn(cys)] (2), [(C6H5)(3)Sn(Hcys).(H2O)] (3), {[(CH3)(2)Sn(KCYS)(2)].2(H2O)} (4), {[(n-C4H9)(2)Sn(KCYS)(2)].2(H2O)} (5) and {[(C6H5)(2)Sn(KCYS)(2)].2(H2O)} (6) (where H(2)cys= L-cysteine) are reported. The compounds have been characterized by elemental analysis and H-1-NMR, Uv-Vis, FT-IR and Mossbauer spectroscopic techniques. Attempted recrystallization of (2) in DMSO/methanol 2:1 solution yielded after several days unexpectedly the dimeric compound bis(tri-phenyltin)sulphide {[(C6H5)(3)Sn](2)S} (7) which has been characterized by x-ray analysis. The structure of the parent complex (2) as well as the mechanism of the decomposition of cysteine are being further investigated. The in vitro anticancer activity of complexes (1) - (6), against human leukemia (HL60), human liver (Bel7402), human stomach (BGC823) and human cervix epithelial human carcinoma (Hela), nasopharyngeal carcinoma (KB) and lung cancer (PG) tumor cells, were evaluated. | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.primary | 10.1155/S1565363304000044 | - |
heal.identifier.secondary | <Go to ISI>://000224303000004 | - |
heal.identifier.secondary | http://downloads.hindawi.com/journals/bca/2004/418579.pdf | - |
heal.journalName | Bioinorg Chem Appl | en |
heal.journalType | peer reviewed | - |
heal.language | en | - |
heal.publicationDate | 2004 | - |
heal.publisher | Freund Publishing House Ltd. | en |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείας | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Πρωτότυπος φάκελος/πακέτο
1 - 1 of 1
Φόρτωση...
- Ονομα:
- Chasapis-2004-Organotin(IV) deriva.pdf
- Μέγεθος:
- 1.12 MB
- Μορφότυπο:
- Adobe Portable Document Format
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: